Michael Bennett
Gastroenterology · San Diego, CANPI 1700895927
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Bristol Myers Squibb at 45.0% of the total. Reporting peaked in 2020 at $4,338 and has fallen 96.3% since, to $161 in 2021.
Across 82 payments — averaging $66.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$2K
- Adare Pharmaceuticals, Inc.$1K
- Novartis$590
- AbbVie$376
- Takeda Pharmaceuticals U.S.A., Inc.$253
- Gilead$152
- plus $499 from 12 others
Across 399 payments — averaging $3668.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$530K
- Gilead$422K
- Intercept Pharmaceuticals, Inc.$162K
- E.r. Squibb & Sons, L.L.C.$132K
- Bristol Myers Squibb$127K
- Pfizer$32K
- plus $59K from 4 others
What the payments were for
- Consulting fees$2,45045%
- Travel & lodging$1,09920%
- Food & beverage$1,87034%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 1 | $2,450 |
| Adare Pharmaceuticals, Inc. | 6 | $1,122 |
| Novartis | 5 | $590 |
| AbbVie(2 entities) | 18 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $253 |
| Gilead | 10 | $152 |
| Intercept Pharmaceuticals, Inc. | 7 | $139 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $79 |
| Ferring Pharmaceuticals Inc. | 4 | $62 |
| Shionogi Inc | 3 | $53 |
| UCB, Inc. | 1 | $27 |
| AMAG Pharmaceuticals, Inc. | 1 | $23 |
| Ironwood Pharmaceuticals, Inc | 2 | $22 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Pfizer | 2 | $18 |
| QOL Medical, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPOSIA$2,450
How this compares
$5,442 in reported general payments places this provider in the 70th percentile of 1,885 gastroenterology providers in California.
Other gastroenterology in San Diego
- William SandbornSan Diego$340K
- David KunkelSan Diego$287K
- Naveen GaraSan Diego$178K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.